Meta Biomed Co., Ltd. (KOSDAQ:059210)
South Korea
· Delayed Price · Currency is KRW 5,080.00
+40.00 (0.79%)
At close: Dec 5, 2025
Meta Biomed Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 99,766 | 94,036 | 83,101 | 68,942 | 58,780 | 44,998 | Upgrade
|
| Other Revenue | - | - | -0 | -0 | -0 | - | Upgrade
|
| Revenue | 99,766 | 94,036 | 83,101 | 68,942 | 58,780 | 44,998 | Upgrade
|
| Revenue Growth (YoY) | 8.09% | 13.16% | 20.54% | 17.29% | 30.63% | -24.23% | Upgrade
|
| Cost of Revenue | 45,277 | 46,675 | 45,110 | 39,746 | 33,778 | 25,389 | Upgrade
|
| Gross Profit | 54,489 | 47,361 | 37,990 | 29,196 | 25,003 | 19,608 | Upgrade
|
| Selling, General & Admin | 25,121 | 23,143 | 21,651 | 18,682 | 15,455 | 13,359 | Upgrade
|
| Research & Development | 4,127 | 5,140 | 4,538 | 4,343 | 3,339 | 2,227 | Upgrade
|
| Operating Expenses | 31,162 | 30,139 | 27,388 | 23,831 | 19,741 | 17,094 | Upgrade
|
| Operating Income | 23,328 | 17,222 | 10,602 | 5,365 | 5,261 | 2,514 | Upgrade
|
| Interest Expense | -3,354 | -3,742 | -2,315 | -1,390 | -1,145 | -1,011 | Upgrade
|
| Interest & Investment Income | 1,203 | 635.32 | 375.03 | 206.78 | 29.82 | 31.36 | Upgrade
|
| Earnings From Equity Investments | 558.7 | - | - | - | 537.62 | 468.69 | Upgrade
|
| Currency Exchange Gain (Loss) | 1,880 | 3,453 | 232.84 | -523.93 | 1,509 | -1,236 | Upgrade
|
| Other Non Operating Income (Expenses) | -3,020 | 4,212 | -861.26 | -734.59 | 1,171 | 433.05 | Upgrade
|
| EBT Excluding Unusual Items | 20,594 | 21,781 | 8,034 | 2,923 | 7,364 | 1,200 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1,188 | 1,530 | 773.17 | 426.74 | -39.83 | -335.36 | Upgrade
|
| Gain (Loss) on Sale of Assets | -33.39 | -13.88 | 12.62 | 47.62 | 801.18 | 180.36 | Upgrade
|
| Asset Writedown | - | - | -1,015 | -487.37 | -541.23 | -4,661 | Upgrade
|
| Pretax Income | 21,749 | 23,297 | 7,805 | 2,910 | 7,584 | -3,616 | Upgrade
|
| Income Tax Expense | 3,476 | 1,146 | -2,223 | 64.5 | -1,938 | -529.21 | Upgrade
|
| Earnings From Continuing Operations | 18,273 | 22,150 | 10,027 | 2,846 | 9,521 | -3,087 | Upgrade
|
| Earnings From Discontinued Operations | -6.06 | 174.43 | -211.99 | 754.18 | 140.51 | -1,003 | Upgrade
|
| Net Income to Company | 18,267 | 22,325 | 9,815 | 3,600 | 9,662 | -4,090 | Upgrade
|
| Minority Interest in Earnings | 108.6 | 77.62 | 265 | -972.22 | -140.45 | -3.75 | Upgrade
|
| Net Income | 18,375 | 22,402 | 10,080 | 2,628 | 9,522 | -4,093 | Upgrade
|
| Net Income to Common | 18,375 | 22,402 | 10,080 | 2,628 | 9,522 | -4,093 | Upgrade
|
| Net Income Growth | 19.76% | 122.24% | 283.61% | -72.40% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 24 | 23 | 23 | 23 | 23 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 27 | 23 | 23 | 23 | 23 | Upgrade
|
| Shares Change (YoY) | -32.66% | 18.55% | -0.06% | -0.07% | -0.61% | -1.08% | Upgrade
|
| EPS (Basic) | 763.28 | 979.63 | 440.75 | 114.82 | 415.77 | -177.66 | Upgrade
|
| EPS (Diluted) | 615.37 | 658.59 | 440.75 | 114.82 | 415.77 | -177.66 | Upgrade
|
| EPS Growth | 52.58% | 49.43% | 283.85% | -72.38% | - | - | Upgrade
|
| Free Cash Flow | 3,810 | 11,719 | -1,271 | -6,236 | 9,069 | 2,634 | Upgrade
|
| Free Cash Flow Per Share | 158.28 | 432.22 | -55.59 | -272.48 | 396.00 | 114.32 | Upgrade
|
| Dividend Per Share | 30.000 | 30.000 | 20.000 | 20.000 | 20.000 | 10.000 | Upgrade
|
| Dividend Growth | 50.00% | 50.00% | - | - | 100.00% | - | Upgrade
|
| Gross Margin | 54.62% | 50.36% | 45.72% | 42.35% | 42.54% | 43.58% | Upgrade
|
| Operating Margin | 23.38% | 18.31% | 12.76% | 7.78% | 8.95% | 5.59% | Upgrade
|
| Profit Margin | 18.42% | 23.82% | 12.13% | 3.81% | 16.20% | -9.10% | Upgrade
|
| Free Cash Flow Margin | 3.82% | 12.46% | -1.53% | -9.04% | 15.43% | 5.85% | Upgrade
|
| EBITDA | 28,753 | 22,203 | 14,825 | 9,225 | 8,832 | 6,455 | Upgrade
|
| EBITDA Margin | 28.82% | 23.61% | 17.84% | 13.38% | 15.02% | 14.35% | Upgrade
|
| D&A For EBITDA | 5,425 | 4,981 | 4,223 | 3,860 | 3,571 | 3,941 | Upgrade
|
| EBIT | 23,328 | 17,222 | 10,602 | 5,365 | 5,261 | 2,514 | Upgrade
|
| EBIT Margin | 23.38% | 18.31% | 12.76% | 7.78% | 8.95% | 5.59% | Upgrade
|
| Effective Tax Rate | 15.98% | 4.92% | - | 2.22% | - | - | Upgrade
|
| Advertising Expenses | - | 298.35 | 151.08 | 230.86 | 245.85 | 141.51 | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.